HLA-B*07 is a high risk allele for familial cervical cancer

Asian Pac J Cancer Prev. 2011;12(10):2597-600.

Abstract

Aim: The purpose of this study was to investigate 50 women from eight families with familial cervical cancer in Wufeng County, Hubei Province, China, a region with a high incidence of cervical cancer. Eighty-nine healthy women, of similar age, location and ethnicity, were selected as a control group.

Methods: Blood samples were collected from both groups, and HLA-A, HLA-B, and HLA-DRB1 genotypes were profiled with the Multi-Analyte Profiling system (xMAP) (Luminex HLA-SSO) using a WAKFlow HLA typing kit. Results were analyzed with Luminex HLA typing software and showed good stability, reproducibility and specificity.

Results: We found several high risk alleles in women with familial cervical cancer, that associated with the highest risk being HLA-B*07 (OR = 8.7, 95% CI = 1.8-41.1).

Conclusions: HLA-B*07 is a high risk allele for cervical cancer, and has strong potential for use as a molecular biomarker.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alleles
  • Biomarkers, Tumor
  • Case-Control Studies
  • China / epidemiology
  • Female
  • Gene Frequency
  • Genes, MHC Class I
  • Genetic Predisposition to Disease*
  • Genotype
  • HLA-B7 Antigen / genetics*
  • Haplotypes
  • Histocompatibility Antigens Class II / genetics
  • Humans
  • Middle Aged
  • Risk Factors
  • Surveys and Questionnaires
  • Uterine Cervical Neoplasms / epidemiology
  • Uterine Cervical Neoplasms / genetics*
  • Young Adult

Substances

  • Biomarkers, Tumor
  • HLA-B*07 antigen
  • HLA-B7 Antigen
  • Histocompatibility Antigens Class II